TriStar Technology Group Information

TriStar Technology Group supports oncology R&D with quality human biospecimens, linked clinical and molecular data, whole-slide images, and integrated laboratory and pathology services. Our Oncology Translational Pathology Repository helps pharma, biotech, diagnostics, and computational pathology teams select materials around their study requirements—from cancer indication and biomarker profile to treatment history and available outcomes. Our offerings include: • FFPE tissue blocks and study-specific cohorts • Tissue microarrays, including selected collections with treatment follow-up and molecular data • Matched plasma and tissue in selected collections • H&E whole-slide images linked to anonymized donor records and source FFPE tissue Medical pathologists help assess tissue suitability and guide sample selection, assay strategy, and interpretation. Additional services include IHC, RNAscope RNA-ISH, multiplex immunofluorescence, molecular profiling, spatial profiling, and digital image analysis. Our established tissue collections are supported by informed consent and ethics approval. Available specimens, matching, clinical fields, and molecular data vary by donor and collection. Discuss your study with us: share your indication, sample format, cohort size, and required clinical or molecular information at https://tristargroup.us/contact-us/